A Comparison of Two Injection Locations in Obese Patients Having Lower Leg/Foot Surgery
Evaluation of Ultrasound-Guided Popliteal Sciatic Nerve Blockade in the Severely and Morbidly Obese Populations
1 other identifier
observational
60
1 country
1
Brief Summary
One technique for the nerve block involves injecting the numbing medicine where the nerve is together (higher up in the back of the thigh). The other technique involves injecting the numbing medicine where the nerve splits into two parts. By injecting numbing medication around the nerve(s), there will be less pain after the procedure. It is thought that the numbing medicine will be easier to inject in the group that the nerves are split. It is expected that subjects may need less pain medication and have lower pain ratings in this group too.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 7, 2012
CompletedFirst Posted
Study publicly available on registry
March 9, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedOctober 14, 2015
October 1, 2015
3.6 years
March 7, 2012
October 13, 2015
Conditions
Keywords
Eligibility Criteria
Severely and morbidly obese patients scheduled for foot or ankle surgery.
You may qualify if:
- Patients ≥ 18 years of age undergoing unilateral foot and/or ankle surgery
- Severe or morbid obesity, defined as a BMI of 35-39 or ≥ 40, respectively
- ASA status I-IV
- Ability to understand and provide informed consent
You may not qualify if:
- True allergy, not sensitivity, to any of the following substances:
- Local Anesthetics Midazolam Fentanyl Hydromorphone Propofol
- Pregnancy
- Evidence of infection at or near the proposed needle insertion site
- Unstable or undetermined neurologic disease of the lower extremity
- Chronic pain patients
- Patient refusal or inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jose Soberon, MDlead
Study Sites (1)
Ochsner Clinic Foundation
New Orleans, Louisiana, 70121, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jose Soberon, MD
Ochsner Health System
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Anesthesiologist
Study Record Dates
First Submitted
March 7, 2012
First Posted
March 9, 2012
Study Start
March 1, 2012
Primary Completion
October 1, 2015
Study Completion
October 1, 2015
Last Updated
October 14, 2015
Record last verified: 2015-10